Cowen Starts Immune Design (IMDZ) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq futures rise as AI stocks rebound ahead of key earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Oil slips from 5-month high as Trump's Russia sanctions waiver may bring more supplies
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Goldman warns high investor conviction could amplify volatility as sentiment shift
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Microsoft pulls out of UK data center deal with Nscale, Telegraph reports
- Lithuanians forced to take shelter after suspected drone enters airspace
- Oil slips from 5-month high as Trump's Russia sanctions waiver may bring more supplies
Immune Design (IMDZ) Tops Q1 EPS by 8c
May 14, 2015 7:00 AM EDTImmune Design (NASDAQ: IMDZ) reported Q1 EPS of ($0.56), $0.08 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $1.3 million.
For earnings history and earnings-related data on Immune Design (IMDZ) click here.
... More


